In short. The hormonal transition changes the skin and the fat beneath it at the same time as the changes usually called ageing. Oestrogen falls, skin has receptors for it, collagen density and thickness reduce faster around the transition, and fat distribution shifts, so a facial plan made before it can need rewriting within a year.
Key points
- The hormonal transition changes skin and fat alongside the changes called ageing.
- Oestrogen falls and skin has receptors for it, so collagen and thickness reduce faster.
- Fat distribution shifts, so some facial volume change is not age alone.
- A plan made without the transition is built on a moving surface.
- It is not a reason to postpone treatment, but a reason for shorter plans and review.
What does the transition change in the face?
Oestrogen falls, and skin has receptors for it. Collagen density and skin thickness reduce faster around the transition than before or after it, and the skin becomes drier and slower to recover. Fat distribution shifts as well, and some of the volume change in the face at this stage runs alongside that shift rather than being caused by age alone. The result is that a face can change noticeably within a year or two, in a way a plan made before it will not have accounted for.
Why does it belong inside the facial plan?
A plan made without it is a plan built on a moving surface. Sessions may need longer intervals because healing is slower, and the areas that need attention may have changed. None of that makes treatment inappropriate. It makes review more important, and a short plan with a review point more useful than a long one with a fixed schedule.
| What changes | What it means for the plan | What the assessment asks | What to review |
|---|---|---|---|
| Collagen density and skin thickness | Healing is slower and the face can change within a year or two | Where you are in the transition | At least yearly against standardised photographs |
| Skin dryness and recovery | Sessions may need longer intervals | What you take and how your skin has responded | Keep intervals generous |
| Fat distribution | The areas needing attention may change | How much of the volume change is not age alone | Reassess rather than repeat last year's step |
| Hormonal treatment | It changes what is reasonable | What you are taking for the transition | Report any change before a procedure |
| Plan length | A long fixed schedule is less useful than a short plan with a review point | Whether the plan has a review point | Keep the plan short and be willing to drop a step |
What the transition does not justify
It does not mean facial treatment should be postponed until the transition is over, which for some people is years and for others has no clear endpoint. Treatment of the transition itself, and whether it is appropriate for you, belongs with the clinician managing it rather than with a facial plan. Keeping those two questions separate is part of planning honestly.
How should a plan be timed around it?
Keep the intervals generous, because healing is slower while the skin is adjusting. Review at least once a year against standardised photographs, and be willing to conclude that a step planned last year is no longer the right one. Report any change in hormonal treatment before a procedure rather than after it, and keep the plan small enough that a year of unexpected change leaves little to reconsider at once.
What should the assessment ask about?
The transition is part of the assessment, not a separate appointment. Where you are in the transition, what you are taking for it and how your skin has responded are clinical facts about the face being treated. They change what is reasonable, so they are asked about before a plan is made rather than mentioned afterwards.
When is a medical review needed rather than a treatment?
Sudden facial hair growth, acne appearing for the first time, or a marked change in skin across a few months needs medical review. So do hot flushes, sleep loss or mood change affecting your health, which is a medical matter rather than an aesthetic one. Any new medicine or hormonal treatment should be reported before a facial plan is made.
What should the transition change about planning?
The transition is not a reason to stop planning. It is a reason to plan in shorter steps, to review honestly, and to keep the question of what is happening in your skin separate from the question of what should be done about it.
Sources
- National Institute for Health and Care Excellence: guidance on menopause and skin and bone health
- American Academy of Dermatology: patient information on skin changes with age and hormonal change
- Cochrane Library: systematic reviews on menopause and skin
Source links open each organisation's search results for the topic. Document-level confirmation is pending the reviewer's sign-off.
Internal links
Frequently asked questions
Should I wait until the transition is over before planning anything?
No. For some people the transition runs for years and for others it has no clear endpoint, so waiting means waiting indefinitely. What changes instead is the shape of the plan: shorter steps, longer intervals because healing is slower while the skin adjusts, and a review point at least once a year rather than a fixed schedule.
Does the transition mean my facial treatment will not last as long?
It means the picture changes while the plan is running, so review matters more than durability figures. Collagen density and skin thickness reduce faster in the years around the transition than before or after it, and fat distribution shifts alongside that. A short plan with a review point is more useful than a long one that assumes nothing will change.
Is facial treatment the same subject as treatment for the transition itself?
No, and the two should not be merged. Whether hormonal treatment is appropriate for you and what it changes is a medical decision belonging to the clinician managing it. A facial plan is separate, and it needs to know where you are in the transition and what you are taking, because those change what is reasonable for your skin.
Risks & Limitations
- Nothing offered at this stage is risk-free, and thin skin carries a higher chance of marks, pigment change and slow healing.
- Bruising is more likely and more prolonged on anticoagulant or antiplatelet medication, and around uncontrolled blood pressure.
- Descent is a change in position rather than in quantity, so adding volume to a jawline that has dropped does not lift it.
- Revision is harder at this stage, because there is less tissue to work with and less elasticity to recover.
When to Seek Care
- Facial drooping, weakness or numbness, which needs urgent assessment rather than aesthetic advice.
- Redness, warmth, discharge or fever after a treatment, which suggests infection rather than normal healing.
- Bruising that spreads rapidly, becomes firm and painful, or appears far from the treated area.
- A neck lump, persistent hoarseness, or difficulty swallowing.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.